Photo by Getty Images
A Yale-Duke collaborative research team may have identified some of the first biomarkers linked to impaired lung function in long-term COVID-19 patients.
Since the early months of the pandemic, scientists have tried to determine why some patients experience symptoms such as shortness of breath, cough, fever, fatigue, or chest pain weeks to months after their initial COVID-19 infection. What may drive or predict the persistence of long-term symptoms, also known as “post-acute sequelae of COVID-19,” remains poorly understood. A study published June 10 in the journal JCI Insight may provide answers about this mysterious condition.
The study, led by Hyung J. Chun, MD, an associate professor of cardiovascular medicine and pathology and co-director of the Yale Cardiovascular Research Center, examined the predictors of persistent illness.